Vivek Subbiah: The state of AI in Precision Oncology
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on LinkedIn:
“Thrilled to announce I’ll be joining an exceptional panel at the Second Annual Virtual Summit on AI in Precision Oncology this December!
Amazing vision by Dr. Douglas Flora, MD, LSSBB, FACCC for spearheading this summit on AI & Precision Oncology.
Looking forward to the fireside chat with the terrific Dr. Sanjay Juneja, M.D. as we explore the transformative potential for AI in precision oncology & drug development.
Join us for dynamic keynotes, engaging panel discussions, and thought-provoking fireside chats with leading oncology experts as well as luminaries in AI.
Plenty of valuable insights and forward-looking perspectives from who’s who in the AI & oncology world.
Thursday, December 12, 2024
8:00 am PT | 11:00 am ET | 17:00 CET
Click here to register.”
Sanjay Juneja, Triple board-certified hematologist and medical oncologist dedicated to democratizing cancer care, reshared the post on LinkedIn, adding:
“He called me terrific real talk though, I hope people can appreciate the MARKED. ACCELERATION. of what and how the brilliant minds of those like Vivek, to date, have had to patiently wedge into bottle neck after bottle neck… in their pursuit of improving our understanding of such a complex disease process.
With AI assisting each and every step of the discovery process that we outline in our talk, you’ll be able to appreciate the enormous potential that lies ahead of ahead us!”
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer. He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials. He has also received the Yvonne Award 2024 by OncoDaily in the “Voice of Oncology” category.
Sanjay Juneja, is a triple board-certified hematologist and medical oncologist dedicated to democratizing cancer care through accessible innovation. Known as TheOncDoc, he has garnered over 700,000 social media followers and hosts the “Target Cancer: Podcast,” which has over one million downloads worldwide. Recognized by the White House as a Healthcare Leader in Social Media, he received the inaugural ‘2024 Oncology Icons’ award from Targeted Oncology. A prominent keynote speaker featured in outlets like CNBC and PBS, Dr. Juneja also consults on effective communication for healthcare professionals and biotech companies. He co-founded Medfluencers for responsible social media education and TensorBlack to enhance AI understanding in oncology.
For more Updates, Follow OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023